首页> 外文期刊>癌と化学療法 >A case of partial response in liver metastatic lesion from gastric endocrine cell carcinoma treated with TS-1
【24h】

A case of partial response in liver metastatic lesion from gastric endocrine cell carcinoma treated with TS-1

机译:TS-1治疗胃内分泌细胞癌肝转移性病变的部分反应1例

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Endocrine cell carcinoma (ECC) of the stomach is a rare pathological type with a poor outcome. Standard chemotherapy has not yet been established. We experienced a case of partial response in the liver metastasis from the gastric ECC treated with TS-1. The patient was a 68-year-old female. An upper GI series and gastroendoscopy revealed pyrolus stenosis and CT-scan showed liver metastasis. A non-curative total gastrectomy was performed to allow oral intake. Since the histopathological examination revealed that tumor cells were partially positive for chromogranin A on immunohistochemical study, we diagnosed tumor ECC of the stomach. The patient with liver metastasis was treated using TS-1, and CT-scan showed a remarkable decrease (PR) in the metastatic lesion. TS-1 administration can improve the clinical outcome for ECC of the stomach.
机译:胃内分泌细胞癌(ECC)是一种罕见的病理类型,预后较差。尚未建立标准化学疗法。我们经历了由TS-1治疗的胃ECC引起的肝转移中部分反应的情况。该患者为68岁的女性。上消化道检查和胃镜检查显示有热管狭窄,CT扫描显示有肝转移。进行非治愈性全胃切除术以允许口服。由于组织病理学检查显示,在免疫组织化学研究中,肿瘤细胞对嗜铬粒蛋白A部分呈阳性,因此我们诊断出胃癌ECC。肝转移患者使用TS-1治疗,CT扫描显示转移灶明显减少(PR)。 TS-1给药可改善胃ECC的临床疗效。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号